Schonfeld Strategic Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-297,000	Closed	-$751K	–	2537
2023 Q4	$751K	Buy	+297,000	New	+$692K	0.01%	1138
2022 Q2	–	Sell	-12,100	Closed	-$97K	–	3167
2022 Q1	$97K	Buy	+12,100	New	+$107K	﹤0.01%	2251

Schonfeld Strategic Advisors's SLGC Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 297,000 shares — an estimated $751K sold.

Schonfeld Strategic Advisors first reported a position in SLGC in Q1 2022 and held it in 2 quarters. The position peaked at $751K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Schonfeld Strategic Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Schonfeld Strategic Advisors sold 297,000 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $751K.
Schonfeld Strategic Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q1 2022 and held it in 2 quarters.
Schonfeld Strategic Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $751K in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.